Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies

Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies

MicroRNAs (miRNAs) and the gut microbiome are key regulators of human health, with emerging evidence highlighting their complex, bidirectional interactions in chronic diseases. miRNAs, influence gene expression and can modulate the composition and function of the gut microbiome, impacting metabolic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lorenzo Drago, Luigi Regenburgh De La Motte, Loredana Deflorio, Delia Francesca Sansico, Michela Salvatici, Emanuele Micaglio, Manuele Biazzo, Fabiana Giarritiello
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Microbiology
Subjects:	miRNA gut microbioma inflammatory bowel disease (IBD) Crohn’s disease (CD) Alzheimer’s disease (AD) major depressive disorder (MDD)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1540943/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review
by: Michalina Jurkiewicz, et al.
Published: (2025-02-01)

Arthralgia and Extraintestinal Manifestations in Crohn’s Disease Elevate the Risk of IBD-Related Arthritis over Sacroiliitis
by: Ivan Giovannini, et al.
Published: (2024-12-01)

Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
by: Mehrnaz Asgharnezhad, et al.
Published: (2025-01-01)

Interrelationships of the Intestinal Microbiome, Trimethylamine N-Oxide and Lipopolysaccharide-Binding Protein with Crohn’s Disease Activity
by: Yelena Laryushina, et al.
Published: (2024-12-01)

Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
by: A. I. Akinshina, et al.
Published: (2019-05-01)

Relationship Between Patient Demographics and Biologic Therapy Use in Inflammatory Bowel Disease. A Single Center Cross‐Sectional Study
by: Mohammad Shehab, et al.
Published: (2025-01-01)

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review
by: Wiktoria Maria Tomaszewska, et al.
Published: (2025-01-01)

The First Saint Petersburg Regional Inflammatory Bowel Diseases Registry on the Basis of the Regional Health Information System: Principles of Functioning, Testing Results, Plan of Development
by: Yu. P. Uspenskiy, et al.
Published: (2023-11-01)

Comparative analysis of dominant gut microbiota in Inflammatory Bowel Disease patients and healthy individuals: A case-control study
by: Alireza Ahmadi, et al.
Published: (2025-04-01)

Features of Crohn's Disease Depending on the Age of Disease Onset
by: E. G. Ganich, et al.
Published: (2023-12-01)

Descripción de las características del microbioma salival en pacientes con trastorno del espectro autista
by: Marcela Arenas González, et al.
Published: (2024-11-01)

Structural equation modeling of the impact of disease activity on inflammatory bowel disease control: the mediating roles of self-efficacy and self-management behaviors
by: Yongli Zhu, et al.
Published: (2025-01-01)

The regenerating gene (Reg) family genes in inflammatory bowel disease (IBD)
by: Shin Takasawa, et al.
Published: (2025-02-01)

New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01)

Management of Anal Fistula with Crohn's Disease
by: Shota Takano, et al.
Published: (2025-01-01)

Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
by: Fang Wang, et al.
Published: (2025-01-01)

Systemic Immune-Inflammation Index: A Promising, Non-Invasive Biomarker for Crohn’s Disease Activity and Severity Assessment
by: Deng Y, et al.
Published: (2025-01-01)

Apical periodontitis in inflammatory bowel disease: a meta-analysis at patient and tooth level
by: Giusy Rita Maria La Rosa, et al.
Published: (2025-02-01)

Fucoidan alleviated colitis aggravated by fiber deficiency through protecting the gut barrier, suppressing the MAPK/NF-κB pathway, and modulating gut microbiota and metabolites
by: Weiyun Zheng, et al.
Published: (2025-01-01)

Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Difficulties the Conservative Treatment of Crohn’s Disease Complicated by Autoimmune Hemophilia A
by: E. L. Belyaeva, et al.
Published: (2020-01-01)

Efficacy of ileostomy in Crohn's disease of the large intestine with perianal involvement
by: Yu. A. Shelygin, et al.
Published: (2011-12-01)

Innovative Assessment of Crohn’s Disease: An Activity Prediction Tool Combining Laboratory Data and Imaging [Letter]
by: Wang F, et al.
Published: (2025-02-01)

α-Methyl-Tryptophan Inhibits SLC6A14 Expression and Exhibits Immunomodulatory Effects in Crohn’s Disease
by: Su Y, et al.
Published: (2025-01-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01)

Prevalence and predictors of severe Crohn’s disease at a tertiary hospital in South Africa
by: C Gounden, et al.
Published: (2024-04-01)

Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01)

Diagnostic interval of inflammatory bowel disease in Chinese children and its relationship with growth parameters: a retrospective study
by: Juan Zhou, et al.
Published: (2025-02-01)

The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01)

Age-related and Gender Aspects of Inflammatory Bowel Diseases in the Republic of Dagestan
by: S. Sh. Akhmedkhanov, et al.
Published: (2022-12-01)

Epidemiology and Treatment Patterns of Fistulizing Crohn’s Disease in a Large, Real-World Australasian Cohort
by: Jack McNamara, et al.
Published: (2025-01-01)

Significance of immune factors in Crohn's disease development
by: D. S. Stavtsev, et al.
Published: (2015-07-01)

Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn’s Disease
by: Brian G. Feagan, et al.
Published: (2025-01-01)

Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01)

Thyroid disorders and inflammatory bowel disease: an association present in adults but also in children and adolescents
by: Valeria Calcaterra, et al.
Published: (2025-02-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
by: Cheng Guo, et al.
Published: (2025-01-01)

Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01)